|
Post by deaner3 on Jun 10, 2017 21:11:19 GMT -5
And I'm the one that made the leap on that last post. I also pay attention to ABT stock because I used to own it and my brother has way too much stock in Abbott so I frequent their stock news. I didn't comment on the post from earlier but it makes sense that it would be mannkind if it isn't just a troll post. But since it didn't mention MNKD and reading this thread from the other day Makes for a nice theory anyway It doesn't mention MannKind by name but it's obvious which company he's referring to ("small company," "newer diabetes drug," "no needles." Probably a hoax, but if not.... Right. As I mentioned it's on StockTwits so lol. Credibility isn't too high but sure would be nice if it is true.
|
|
|
Post by peppy on Jun 10, 2017 21:25:10 GMT -5
I AGREE with SAYHEY24. Based on what I heard and saw on Saturday The TYPE 2 market might be the Holy Grail of treatment. Listening to both Mike's Pharmacy interview, The ASM panel and Dr. Edelman on Saturday. The most uncompliant diabetic is the Type 2. Especially the one who has avoided treatment until they were really sick. At some time in the past Al Mann referred to these Type 2 folks as being in the lost decade of treatment. MannKind is addressing this with the way they have been talking about TITRATION regiments. Mike himself said in the Pharmacy clip that you can take Afrezza right at meal time and it works within 15 mins instead of more than an hours for injected Insulin. That the patient could take a follow up dose based on their CGM numbers. Interesting enough Edelman was very high on the Abott product and thought it would be an over the counter device within a short time like it was in other markets with the exception of the USA. He said it was silly or sad that a patient had to use the Libre currently by having to go to the Endo for calibration and reading. He said that it would enable patients to be active in their own treatment. So it fits the narrative that perhaps there might be some type of alliance between Mannkind and Abbott's sales team. We all know that something good is in our future. KC - thanks but let me set the record straight as Stefan Schwarz from Sanofi was the guy who saw afrezza as the perfect fit for the T2 market. After I thought about it I began to agree to Schwarz and I think Schwarz still believes it. He just needed a way to change how PCPs were treating T2s and Onduo is his bet. Now, Edleman has been working with Schwarz and Onduo from the beginning and I got one of those Libre's on Ebay 2 years ago from England. The next day after taking it out of the box I started telling people Dexcom was doomed as CGMs will become a commodity market. The Libre is great for the price. Edleman is right. I was told today it should be available without prescription but I was surprise that they think they will also get it approved for dosing. Also, there is already a 3rd party android interface but Dachis should be able to do better. If he needs help he can contact me. He needs the Dexcom/IWatch interfaced and the Abbott right into his tracking system and he needs this ASAP to be getting it ready for Amazon. I sure hope ALL these guys show up at the ADA Sunday 2pm session on "Should T2s be using CGMs" and pack the room and come with very loud voices. I am really surprised Mike is not sending around a petition like he did for Dexcom to help change the current T2 step process for presentation at this session. quote: I got one of those Libre's on Ebay 2 years ago from England. The next day after taking it out of the box I started telling people Dexcom was doomed as CGMs will become a commodity market. The Libre is great for the price.
reply: Sayhey, are you diabetic? Did I type that correctly? Do you have diabetes?
|
|
|
Post by timri on Jun 10, 2017 21:50:50 GMT -5
It doesn't mention MannKind by name but it's obvious which company he's referring to ("small company," "newer diabetes drug," "no needles." Probably a hoax, but if not.... Right. As I mentioned it's on StockTwits so lol. Credibility isn't too high but sure would be nice if it is true. This is getting out of hand. Buckeye1978 newly registered on StockTwits June 10th. Name George smith lol first post says he's a janitor.... Get a picture of him in his janitor outfit with his ID badge and Ill start a gofundme page for him to buy mnkd stock.
|
|
|
Post by deaner3 on Jun 10, 2017 21:59:28 GMT -5
Right. As I mentioned it's on StockTwits so lol. Credibility isn't too high but sure would be nice if it is true. This is getting out of hand. Buckeye1978 newly registered on StockTwits June 10th. Name George smith lol first post says he's a janitor.... Get a picture of him in his janitor outfit with his ID badge and Ill start a gofundme page for him to buy mnkd stock. Getting out of hand ? It's been out of hand for a long time on both sides.
|
|
|
Post by sportsrancho on Jun 11, 2017 7:53:54 GMT -5
This is getting out of hand. Buckeye1978 newly registered on StockTwits June 10th. Name George smith lol first post says he's a janitor.... Get a picture of him in his janitor outfit with his ID badge and Ill start a gofundme page for him to buy mnkd stock. Getting out of hand ? It's been out of hand for a long time on both sides. I think things like this depend on what you've already been thinking. Like I think a lot more about Abbott being a partner than Amgen. So it did pipe my interest a little bit:-)
|
|
|
Post by agedhippie on Jun 11, 2017 20:10:52 GMT -5
KC - thanks but let me set the record straight as Stefan Schwarz from Sanofi was the guy who saw afrezza as the perfect fit for the T2 market. After I thought about it I began to agree to Schwarz and I think Schwarz still believes it. He just needed a way to change how PCPs were treating T2s and Onduo is his bet. Now, Edleman has been working with Schwarz and Onduo from the beginning and I got one of those Libre's on Ebay 2 years ago from England. The next day after taking it out of the box I started telling people Dexcom was doomed as CGMs will become a commodity market. The Libre is great for the price. Edleman is right. I was told today it should be available without prescription but I was surprise that they think they will also get it approved for dosing. Also, there is already a 3rd party android interface but Dachis should be able to do better. If he needs help he can contact me. He needs the Dexcom/IWatch interfaced and the Abbott right into his tracking system and he needs this ASAP to be getting it ready for Amazon. I sure hope ALL these guys show up at the ADA Sunday 2pm session on "Should T2s be using CGMs" and pack the room and come with very loud voices. I am really surprised Mike is not sending around a petition like he did for Dexcom to help change the current T2 step process for presentation at this session. quote: I got one of those Libre's on Ebay 2 years ago from England. The next day after taking it out of the box I started telling people Dexcom was doomed as CGMs will become a commodity market. The Libre is great for the price.
reply: Sayhey, are you diabetic? Did I type that correctly? Do you have diabetes?
I probably shouldn't bury this in here but this is a good posting on the Libre ( Freestyle libre reliability) with pros and cons from someone who was on the HART trial. The whole thread is worth reading but this post is particularly interesting.
|
|
|
Post by peppy on Jun 11, 2017 21:02:29 GMT -5
quote: I got one of those Libre's on Ebay 2 years ago from England. The next day after taking it out of the box I started telling people Dexcom was doomed as CGMs will become a commodity market. The Libre is great for the price.
reply: Sayhey, are you diabetic? Did I type that correctly? Do you have diabetes?
I probably shouldn't bury this in here but this is a good posting on the Libre ( Freestyle libre reliability) with pros and cons from someone who was on the HART trial. The whole thread is worth reading but this post is particularly interesting. aged does the dexcom5 give more accurate blood glucose reading than libre? (since they are both interstitial.)
|
|
|
Post by kuka on Jun 11, 2017 21:21:49 GMT -5
agreed...could be a negotiating strategy to speed things up ... might also be reason Mike C became CEO ...to stop further deals that might take profits from any buyer
|
|
|
Post by agedhippie on Jun 11, 2017 21:35:52 GMT -5
I probably shouldn't bury this in here but this is a good posting on the Libre ( Freestyle libre reliability) with pros and cons from someone who was on the HART trial. The whole thread is worth reading but this post is particularly interesting. aged does the dexcom5 give more accurate blood glucose reading than libre? (since they are both interstitial.) The Dexcom has algorithms designed to extrapolate the reading to overcome the delay. Also it takes varying amounts of time for level changes to propagate to different parts of your body. The G5 is worn on the abdomen which is relatively quick (5 minute lag I think) whereas the Libre is worn on the arm which is 10 to 15 minutes behind. The Dexcom takes samples once every 5 minutes whereas the Libre is once every 15 minutes. The Libre is good for showing trends. I wouldn't dose off it though. This from the Libre site: 40% of the time it's telling you that you have a hypo it is wrong!!!
|
|